Celgene signs brace of immuno-oncology deals with US biotechsDespite a looming takeover by Bristol-Myers Squibb, Celgene hasn’t stopped making pipeline-boosting deals. It’s just added two more Share XCelgene signs brace of immuno-oncology deals with US biotechshttps://pharmaphorum.com/news/celgene-signs-brace-of-immuno-oncology-deals-with-us-biotechs/
